Volume 24, Issue 4 - Writing for Lay Audiences

Medical writing for two audiences – The RMP public summary

Authors: Kerstin Prechtel, Stefanie Rechtsteiner

Abstract

Download the full article

References

1. Good pharmacovigilance practices. European Medicines Agency [cited 2015 July 13]. Available from: http://www.ema.europa.eu<http//www.ema.europa.eu/%3E/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp
2. Von Bruchhausen T, Prechtel K. Pharmacovigilance medical writing: An evolving profession. Med Writing. 2015;24(2):66–71.
3. Guideline on good pharmacovigilance practices (GVP). Module V – Risk management systems (Rev 1). European Medicines Agency and Heads of Medicines Agencies; 2014 Apr 15 [cited 2015 July 13]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129134.pdf
4. Risk-management plans. European Medicines Agency [cited 2015 August 18]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000360.jsp&mid=WC0b01ac058067a113
5. Guidance on format of the risk management plan (RMP) in the EU – in integrated format. European Medicines Agency [cited 2015 August 20]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2012/11/WC500134650.pdf
6. European public assessment reports. European Medicines Agency [cited 2015 July 13]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124
7. Pharmacovigilance Risk Assessment Committee (PRAC). European Medicines Agency [cited 2015 July 13]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000537.jsp&mid=WC0b01ac058058cb18
8. Committee for Medicinal Products for Human Use (CHMP). European Medicines Agency [cited 2015 July 13]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000094.jsp&mid=WC0b01ac0580028c79
9. Questions and answers on the risk management plan (RMP) summary. European Medicines Agency; 2014 May 05 [cited 2015 July 13]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/05/WC500166101.pdf